News and Trends / Cannabis

Minnesota Study Adds to Growing Evidence Medical Marijuana Reduces Opioid Use

This study, plus an earlier on in Israel, bolsters anecdotal evidence that in states where marijuana is legal, opioid overdoses decline.
Minnesota Study Adds to Growing Evidence Medical Marijuana Reduces Opioid Use
Image credit: Jupiterimages | Getty Images
Guest Writer
Easy Search. Quality Finds. Your partner and digital portal for the cannabis community.
3 min read
Opinions expressed by Green Entrepreneur contributors are their own.

Could at least a partial solution to the opioid crisis be sitting on the shelves at the local medical marijuana dispensary? A new report out of Minnesota, and one earlier this year from Israel, both found that marijuana is beneficial to people with chronic pain conditions and those suffering from cancer.

More than half the participants in the Minnesota study found that cannabis offered a high level of benefit in treating chronic pain.

In addition to alleviating pain and anxiety and improving sleep, the use of medical marijuana also led many in the studies to either reduce or eliminate the use of prescription pain medication.

Related: Detroit, Bankrupt a Few Years Ago, Seems Uninterested In Reaping Medical Marijuana Millions Now

Marijuana In Minnesota

Minnesota voters first approved the use of medical marijuana in 2014, with patients enrolling into the state program in July 2015.

In August 2016, the state added “intractable pain” to the list of conditions approved for treatment with medical marijuana. The state defines intractable pain as “pain whose cause cannot be removed and, according to generally accepted medical practice, the full range of pain management modalities appropriate for this patient has been used without adequate result or with intolerable side effects.”

"Intractable pain" is often treated with opioids. To determine the effectiveness of the program, the state commissioned a $51,000 study of patients in the first five months that intractable pain qualified as a condition treatable with medical marijuana. The study focused on 2,245 patients enrolled in the medical marijuana program for intractable pain between August and December of 2016. About 64 percent of the patients were between the ages of 36 and 64, while 52 percent were female. The vast majority lived in the Minneapolis-St. Paul area.

Related: The Opioid Crisis Is Forcing Open Minds About the Lifesaving Potential of Medical Marijuana

Many of the patients entering the medical marijuana program were taking pain medications. According to the study, 62.6 percent of the patients were able to reduce or eliminate use of opioids after six months in the program. The study also found that:

  • 54 percent of patients said medical marijuana provided a high level of benefit
  • 62 percent reported a reduction in the severity of their pain
  • 27 percent reported an improvement in their ability to sleep well
  • Other benefits mentioned by patients included decreased anxiety and improved mobility and function

The patients also offered statements about the use of medical marijuana. One patient wrote, “This program has opened up a world for me I thought I lost. I started on this just a few short months ago and am totally off my (prescription pain medication). I also have had less spasms and cramping throughout my body. I even chanced getting on a motorcycle and going for a short ride with a friend before it snowed. Thought I’d never do that again.”

Others reported a reduction in pain but said the effect tapered off over time.

The study mirrors previous findings in the Israeli study, which involved patients diagnosed with cancer. The study in Israel reported that using medical marijuana also led to patients reducing or eliminating the use of opioids. The study concluded that cannabis is a “well tolerated, effective and safe option to help patients cope with the malignancy related symptoms.”

Lihi Bar-Lev Schleider, lead researcher on the study, told Rolling Stone, “Cannabis is a very good alternative to reduce opioid consumption, to increase quality of life, and to reduce pain, nausea and vomiting."

Follow dispensaries.com on Twitter to stay up to date on the latest cannabis news.

By Javier Hasse
From retailers to growers, producers, and suppliers, there’s a seemingly never-ending list of startup opportunities in this emerging market. In Start Your Own Cannabis Business, marijuana, biotech, and entrepreneurship reporter Javier Hasse introduces forward-thinking entrepreneurs like you to the industry and shares hard-earned tips and success stories from pioneers and visionaries in the marijuana industry.
Learn More

Latest on Green Entrepreneur

My Queue

There are no Videos in your queue.

Click on the Add to Queue next to any video to save to your queue.

There are no Articles in your queue.

Click on the Add to Queue next to any article to save to your queue.

Podcasts episodes coming soon for GreenEntrepreneur.com

There are no Podcasts in your queue.

Click on the Add to Queue next to any podcast episode on Entrepreneur.com to save to your queue.

You're not following any authors.

Click the Follow button on any author page to keep up with the latest content from your favorite authors.

Report: Sales of Cannabis Concentrates Expected to Triple to $8.5B by 2022

Entrepreneur Media, Inc. values your privacy. In order to understand how people use our site generally, and to create more valuable experiences for you, we may collect data about your use of this site (both directly and through our partners). The table below describes in more detail the data being collected. By giving your consent below, you are agreeing to the use of that data. For more information on our data policies, please visit our Cookie Policy.

Name Category
Google Ad Serving, Ad Targeting, Analytics/Measurement, Optimisation
Rubicon Ad Serving
Teads Ad Serving
Nativo Ad Serving
Teads Ad Serving
New Relic Analytics/Measurement
Log Entries Analytics/Measurement
Sailthru Content Customization